Background and Purpose— Atherosclerosis is a diffuse, chronic inflammatory disorder that
involves the vascular, metabolic, and immune systems and leads to plaque vulnerability. The …

Intracerebral haemorrhage (ICH) still represents the most feared complication of thrombolysis.
Our aim was to review the literature regarding clinical, biological and imaging predictors …

Background and Purpose— Herniation attributable to unilateral mass effect is the major cause
of death in cerebral venous thrombosis (CVT). Decompressive surgery may be lifesaving …

Background and Purpose—The safety and the effectiveness of the surgical treatment of
spontaneous intracerebral hemorrhage (ICH) remain controversial. To investigate the feasibility …

Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after
vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford–AstraZeneca) and Ad26.…

Background and Purpose— Intravenous tissue plasminogen activator improves outcome after
ischemic stroke when given within 3 hours of symptoms onset in carefully selected patients…

Background and Purpose— There has been speculation that the risk of secondary symptomatic
intracranial hemorrhage (SICH) may be increased after thrombolytic therapy in ischemic …

Background Patients who have had a stroke with unknown time of onset have been previously
excluded from thrombolysis. We aimed to establish whether intravenous alteplase is safe …

Objective The risk for symptomatic intracerebral hemorrhage (sICH) associated with thrombolytic
treatment has not been evaluated in large studies using diffusion‐weighted imaging (…

Objectives To assess the efficacy and safety profile of stent-retriever thrombectomy (SRT) in
acute anterior ischemic stroke patients with tandem occlusion. Materials and methods Using …